Table 1

Clinicopathological characteristics of the patients included in the study

No of cases (%)
Histological subtype
 High-grade serous carcinoma10 (90.9)
 Low-grade serous carcinoma1 (9.1)
FIGO staging
 II B1 (9.1)
 III B1 (9.1)
 IV B1 (9.1)
 III C7 (63.6)
 NA1 (9.1)
Familiar history
 Suggestive for HBOC syndrome3 (27.3)
 Non-suggestive for HBOC syndrome8 (72.7)
  • FIGO, International Federation of Gynecology and Obstetrics; HBOC, Hereditary Breast and Ovarian Cancer; NA, not available.